Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | FBP1 | P09467 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7631084 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A | |
| SCHEMBL6436967 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A | |
| SCHEMBL11600944 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A | |
| SCHEMBL6439767 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A | |
| SCHEMBL2138985 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A | |
| SCHEMBL3002303 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A | |
| SCHEMBL1565614 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A | |
| Lithium Ion SCHEMBL193641 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A | |
| SCHEMBL4339905 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A | |
| SCHEMBL7626992 | 0.95 | PPARG (0.52) | PPARGLMNANFE2L2PKMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180163056-A1 | HYDROPHILIC CURABLE COMPOSITIONS | MITSUI CHEMICALS, INC. (JP) | 2018-06-14 | — | — | US | disclosed |
| US-9976049-B2 | Hydrophilic monolayer films | MITSUI CHEMICALS, INC. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20180036995-A1 | HYDROPHILIC MONOLAYER FILM WITH OPTICAL FUNCTIONALITY AND STACK OF THE SAME | MITSUI CHEMICALS, INC. (JP) | 2018-02-08 | — | — | US | disclosed |
| EP-3270192-A1 | HYDROPHILIC SINGLE-LAYER FILM HAVING OPTICAL FUNCTIONALITY, AND LAMINATE THEREOF | Mitsui Chemicals, Inc. (JP) | 2018-01-17 | — | — | EP | disclosed |
| EP-3147336-A1 | HYDROPHILIC SINGLE-LAYER FILM | Mitsui Chemicals, Inc. (JP) | 2017-03-29 | — | — | EP | disclosed |
| US-20170044393-A1 | HYDROPHILIC MONOLAYER FILMS | MITSUI CHEMICALS, INC. (JP) | 2017-02-16 | — | — | US | disclosed |
| EP-3081578-A1 | COMPOSITION FOR HYDROPHILIC CURED PRODUCT | Mitsui Chemicals, Inc. (JP) | 2016-10-19 | — | — | EP | disclosed |
| US-20100197886-A1 | MODIFIED POLYMER COMPLEX, COMPLEX MONOMER, POLYMER COMPLEX, AND REDOX,CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197886-A1 | MODIFIED POLYMER COMPLEX, COMPLEX MONOMER, POLYMER COMPLEX, AND REDOX,CATALYST | MT-CO3, MICOS13, AP3M1 | PPARG 4011/4885LMNA 3951/4885NFE2L2 991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.